A mixture of thromboplastin with calcium chloride freeze-dried, 3 bottles of 8 ml, pack;00020006300 apttv liquid reagent with synthetic phospholipids, package;00020004200 control of fibrinogen, low level, pack;a set of reagents for determining thrombin time, 200 macro or 400 microdefinitions, pack;set
antithrombin iii, for sysmex ca, 6 * 5ml (4x12; 4x2; 2x5 ml), a flask.
Coagulation test revealed
antithrombin III (AT III) defciency [repeated twice at different times, result: 68 (80-120)].
The main factor is the coagulation factor leak, notably because of the
antithrombin III.
Of the coagulation parameters, while prothrombin and partial thromboplastin times, protein S and factors 2, 5, 8, 9, 10 and 11, were determined as normal,
antithrombin III (15.
8] Predisposing condition for MVT include hypercoaguable states like Factor V mutation,
Antithrombin III, Protein C,S deficiency, vasculitis, malignancy, oral contraceptives, Cirrhosis and portal hypertension, acute pancreatitis or any previous surgery.
Antithrombin III (AT) is synthesized in liver and changes in its levels are associated with the extent of cirrhosis.
While
antithrombin III, protein C and protein S deficiencies are the most common causes of thrombophilia, these factors were found to be normal in four patients (Table 1).
The patient was advised to get her protein C, protein S and
antithrombin III levels checked.
Antinuclear antibody (ANA), protein C, S and
antithrombin III tests were all negative.
KEY WORDS:
Antithrombin III Factor V Leiden Protein C Protein S Thrombophilia.
The pathogenesis involves acute transient decreases in proteins C and S, or
antithrombin III levels.
Effect of heparin and warfarin on
antithrombin III.
